Patent EP0187487A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0187487A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Benzothiophenes and benzofurans having antiallergic activity

Assignee: Warner Lambert Co LLC
•
Filing: 1985-12-10
•
Granted: —
•
Expires: 2005-12-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is disclosed a compound having the following general formula (I) or a pharmaceutically acceptable salt thereof, wherein: R', R 4 , and R 5 are each, independently, H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, a hydroxy, an aryl, a nitro group, an amino group, a substituted amino group, a mercapto radical, an alkylthio radical having from one to four carbon atoms, an alkylsulphinyl radical having from one to four carbon atoms, an alkylsulphonyl radical having from one to four carbon atoms, an arylthio radical, an arylsulphinyl radical, an arylsulphony radical or a halogen, R 1 being further chosen from a methylenedioxy radical attached to adjacent carbon atoms of the benzene ring; R 2 is an alkoxy having from one to twelve carbon atoms, an arylmethoxy, an amino group, a substituted amino group, a mercapto group, an alkylthio having from one to four carbon atoms, an alkylsulphinyl having from one to four carbon atoms, an alkylsulphonyl having from one to four carbon atoms, an arylthio, an arylsulphinyl, or an arylsulphonyl; and R 3 is A or B X is oxygen or S(O)q wherein q is zero, one, or two. Also disclosed is a process for preparing the compounds, compositions comprising the compounds and pharmaceutical uses of the compounds. The novel benzothiophene and benzofuran derivatives have antiallergic activity. The disclosure describes the use of derivatives for prevention of the release of mediators including histamine and leukotrienes from basophils and mast cells, and prevent respiratory burst in neutrophils providing activity useful in cardiovascular disorders as well as in antiinflammatory, psoriasis, and antimigraine treatment.

Inventors

  • 👤 David T. Connor
  • 👤 Wiaczeslaw A. Cetenko
  • 👤 Paul C. Unangst
  • 👤 Elizabeth A. Johnson

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-01 17:04
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/92; C07D407/00; C07D407/02; C07D407/04; A; A61; A61P; A61P29/00; A61P37/00; A61P37/08; C07C; C07C323/00; C07D307/78; C07D307/82; C07D307/84; C07D307/85; C07D307/86; C07D333/00; C07D333/50; C07D333/52; C07D333/62; C07D333/68; C07D333/70; C07D405/00; C07D405/02; C07D405/04; C07D405/12; C07D407/12; C07D409/00; C07D409/02; C07D409/04; C07D409/12

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 304 words
A process for preparing a compound having the following general formula (I) or a pharmaceutically acceptable salt thereof, wherein: R 1 , R 4 , and R 5 are each, independently, H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, a hydroxy, an aryl, a nitro group, an amino group, a substituted amino group, a mercapto radical, an alkylthio radical having from one to four carbon atoms, an alkylsulphinyl radical having from one to four carbon atoms, an alkylsulphonyl radica having from one to four carbon atoms, an arylthio radical, an arylsulphinyl radical, arylsulphony radical or a halogen, R 1 being further chosen from a methylenedioxy radical attached to adjacent carbon atoms of the benzene ring; R 2 is an alkoxy having from one to twelve carbon atoms, an arylmethoxy, an amino group, a substituted amino group, a mercapto group, an alkylthio having from one to four carbon atoms, an alkylsulphinyl having from one to four carbon atoms, an alkylsulphonyl having from one to four carbon atoms, an arylthio, an arylsulphinyl, or an arylsulphonyl; and R 3 is A or B X is oxygen or S(O)q wherein q is zero, one, or two; which process comprises: reacting a compound of the formula (III) with a compound of the formula (II 1 ) in the presence of a coupling agent to obtain a compound of the formula (I) in which R 3 is A; or treating a compound of the formula (III) to obtain a compound of the formula (IV) and reacting the compound of formula (IV) with sodium azide and ammonium chloride to obtain a compound of the formula (I) in which R 3 is B ; and,if desired, further reacting the thus formed compound of formula (I) to obtain a pharmaceutical salt thereof.
Claim 2
Dependent Claim 304 words
A process for preparing a compound having the following general formula (I) or a pharmaceutically acceptable salt thereof, wherein: R 1 , R 4 , and R 5 are each, independently, H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, a hydroxy, an aryl, a nitro group, an amino group, a substituted amino group, a mercapto radical, an alkylthio radical having from one to four carbon atoms, an alkylsulphinyl radical having from one to four carbon atoms, an alkylsulphonyl radica having from one to four carbon atoms, an arylthio radical, an arylsulphinyl radical, arylsulphony radical or a halogen, R 1 being further chosen from a methylenedioxy radical attached to adjacent carbon atoms of the benzene ring; R 2 is an alkoxy having from one to twelve carbon atoms, an arylmethoxy, an amino group, a substituted amino group, a mercapto group, an alkylthio having from one to four carbon atoms, an alkylsulphinyl having from one to four carbon atoms, an alkylsulphonyl having from one to four carbon atoms, an arylthio, an arylsulphinyl, or an arylsulphonyl; and R 3 is A or B X is oxygen or S(O)q wherein q is zero, one, or two; which process comprises: reacting a compound of the formula (III) with a compound of the formula (II 1 ) in the presence of a coupling agent to obtain a compound of the formula (I) in which R 3 is A; or treating a compound of the formula (III) to obtain a compound of the formula (IV) and reacting the compound of formula (IV) with sodium azide and ammonium chloride to obtain a compound of the formula (I) in which R 3 is B ; and,if desired, further reacting the thus formed compound of formula (I) to obtain a pharmaceutical salt thereof.
Claim 3
Dependent Claim 10 words
A process according to Claim 1, wherein X is sulphur.
Claim 4
Dependent Claim 10 words
A process according to Claim 1, wherein X is oxygen.
Claim 5
Dependent Claim 19 words
A process according to Claim 1, 2 or 3, wherein R 3 is A as defined in Claim 1.
Claim 6
Dependent Claim 19 words
A process according to Claim 1, 2 or 3, wherein R 3 is B as defined in Claim 1.
Claim 7
Dependent Claim 19 words
A process according to Claim 4, when appendant to Claim 2, in which the following compound is prepared: 5-methoxy-3-(1-methylethoxy)-N-1H-tetrazol-5-yl-benzo-[b]thiophene-2carboxamide.
Claim 8
Dependent Claim 13 words
A process according to Claim 6, wherein the compound is the arginine salt.
Claim 9
Dependent Claim 13 words
A process according to Claim 6, wherein the compound is the sodium salt.
Claim 10
Dependent Claim 45 words
A process according to Claim 4 when appendant to Claim 2 in which one of the following compounds is prepared: 3-ethoxy-5-methoxy-N-1H-tetrazol-5-yl-benzo[b]thiophene-2-carboxamide; 7-methoxy-3-(1-methylethoxy)-N-1H-tetrazol-5-yl-benzo-[b]thiophene-2-carboxamide; 3-(1-methylethoxy)-5-methyl-N-1H-tetrazol-5-yl-benzo [b]thiophene-2-carboxamide. 6-chloro-3-(1-methylethoxy)-N-1H-tetrazol-5-yl-benzo [b]thiophene-2-carboxamide; 3-methoxy-N-1H-tetrazol-5 - yl-benzo[b]thiophene-2-carboxamide; 5-chloro-3-(1-methylethoxy)-N-1H-tetrazole-5-yl-benzo-[b]thiophene-2-carboxamide; 3-(1,1-dimethylethoxy)-5-methoxy-N-1H-tetrazol-5-yl- benzo[b]thiophene-2-carboxamide; 3-(1-methylethoxy)-5-nitro-N-1H-tetrazol-5-yl-benzo[b]-thiophene-2-carboxamide; 3,5-dimethoxy-N-1H-tetrazol-5-yl-benzo[b]thiophene-2-carboxamide; 6-methoxy-3-(1-methylethoxy)-N-1H-tetrazol-5-yl-benzo-[b]thiophene-2-carboxamide; 3-(-1methylethoxy)-N-1H-tetrazol-5-yl-benzo(b]thiophene-2-carboxamide; 3-chloro-N-1H-tetrazol-5-yl-benzo[b]thiophene-2-carboxamide; 5-methoxy-3-[ (1-methylethyl)thio]-N-1H-tetrazol-5-yl- benzothiophene-2-carboxamide; and 3-[(1-methylethylethyl]-N-1H-tetrazol-5-yl-benzo[b]th- io p hene-2-carboxamide.
Claim 11
Dependent Claim 23 words
A process according to Claim 5 when appendant to Claim 2 in which one of the following compounds is prepared: 5-[5-methoxy-3-(1-methylethoxy)-benzo[b]thien-2-yl]-1H-tetrazole; and 5-[3-(1-methylethoxy)benzo[b]thien-2-yl]-1H-tetrazole.
Claim 12
Dependent Claim 55 words
A process according to Claim 4 when appendant to Claim 3, in which one of the following compounds is prepared: 3-methoxy-5-phenyl-N-1H-tetrazol-5-yl-2-benzofurancar- boxamide; 3-ethoxy-5-phenyl-N-1H-tetrazol-5-yl-2-benzofurancarb- oxamide; 3-(1-methylethoxy)-5-phenyl-N-1H-tetrazol-5-yl-2-benzo- furancarboxamide; 3-methoxy-7-phenyl-N-1H-tetrazol-5-yl-2-benzofurancarb- oxamide; 3-ethoxy-7-phenyl-N-1H-tetrazol-5-yl-2-benzofurancarb- oxamide; 3-(1-methylethoxy)-7-phenyl-N-1H-tetrazol-5-yl-2-benz- ofurancarboxamide; 3,6-dimethoxy-N-1H-tetrazol-5-yl-2-benzofurancarbox- amide; 3,5-dimethoxy-N-1H-tetrazol-5-yl-2-benzofurancarbox- amide; 6-methoxy-3-phenylmethoxy-N-1H-tetrazol-5-yl-2-benzofu- rancarboxamide; 3,7-dimethoxy-N-1H-tetrazol-5-yl-2-benzofurancarbox- amide; 3-nonyloxy-7-methoxy-N-1H-tetrazol-5-yl-2-benzofuranc- arboxamide; 3-acetylamino-N-1H-tetrazol-5-yl-2-benzofurancarbox- amide; 3-methoxy-N-(1H-tetrazol-5-yl)-naphtho[2,3-b]furan-2-carboxamide; 5-methoxy-3-(1-methylethoxy)-N-1H-tetrazol-5-yl-2-ben- zofurancarboxamide; 5-methoxy-3-phenylmethoxy-N-1H-tetrazol-5-yl-2-benzofu- rancarboxamide; 6-methoxy-3-(1-methylethoxy)-N-1H-tetrazol5-yl-2-ben- zofurancarboxamide; 7-methoxy-3-(1-methylethoxy)-N-1H-tetrazol-5-yl-2-ben- zofurancarboxamide; and 3-amino-N-1H-tetrazol-5-yl-2-benzofurancarboxamide.
Claim 13
Dependent Claim 26 words
A processaccording to Claim 5 when appendant to Claim 3, in which one of the following compounds is prepared: 5-(3-amino-2-benzofuranyl)-1H-tetrazole ? 5-(3,6-dimethoxy-2-benzofuranyl)-1H-tetrazole; 5-(3,5-dimethoxy-2-benzofuranyl)-1H-tetrazole; 5-(3,7-dimethoxy-2-benzofuranyl)-1H-tetrazole; and 5-(3-acetylamino-2-benzofuranyl)-lH-tetrazole.
Claim 14
Dependent Claim 29 words
A process for preparing pharmaceutical composition comprising combining an effective amount of a compound prepared in accordance with any preceding claim together with a pharmaceutically acceptable carrier or diluent.
Claim 15
Dependent Claim 37 words
For use in a method of treating allergies in mammals, an effective amount of a compound prepared in accordance with any one of Claims 1 to 12 or a pharmaceutical composition prepared in accordance with Claim 13.

References Cited (Backward Citations)

US3452039A Cited
US4432986A Cited
EP0146243A1 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag